AOTI, Inc.
$58.44-2.60%($-1.56)
TickerSpark Score
69/100
57
Valuation
70
Profitability
55
Growth
64
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AOTI.L research report →
52-Week Range45% of range
Low $25.00
Current $58.44
High $99.00
Companyaotinc.net
AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System.
- CEO
- Michael Griffiths
- IPO
- 2024
- Employees
- 85
- HQ
- Oceanside, US
Price Chart
-27.27% · this period
Valuation
- Market Cap
- $62.16M
- P/E
- 110.86
- P/S
- 2.06
- P/B
- 3.50
- EV/EBITDA
- 21.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 52.40%
- Op Margin
- 7.33%
- Net Margin
- 1.86%
- ROE
- 3.19%
- ROIC
- 2.77%
Growth & Income
- Revenue
- $58.36M · 32.88%
- Net Income
- $-1,756,000 · 78.55%
- EPS
- $-0.02 · -302.44%
- Op Income
- $1.25M
- FCF YoY
- -184.22%
Performance & Tape
- 52W High
- $99.00
- 52W Low
- $25.00
- 50D MA
- $45.14
- 200D MA
- $41.55
- Beta
- 1.22
- Avg Volume
- 30.15K
Get TickerSpark's AI analysis on AOTI.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AOTI.L Coverage
We haven't published any research on AOTI.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AOTI.L Report →